Hemodynamically-guided management using an implanted pulmonary artery pressure sensor is indicated to reduce heart failure (HF) hospitalizations in patients with New York Heart Association (NYHA) functional class II-III with a prior HF hospitalization or those with elevated natriuretic peptides.
JACC Heart Failure Editor-in-ChiefBiykem Bozkurt, MD, PhD, FACC
Deputy EditorAkshay S. Desai, MD, MPH
JACC Heart Failure CME/MOC EditorKenneth A. Ellenbogen, MD
AuthorMichael H. Beasley, MD
Important Dates
Date of Release: November 28, 2022Term of Approval/Date of CME/MOC/ECME Expiration: November 27, 2023